• Enhance the integration of menopause-related care into primary and specialty clinical practice.
• Address knowledge gaps and clarify controversies surrounding hormone therapy and emerging therapeutic options.
• Promote critical evaluation of common symptoms in midlife women, including brain fog, breast changes, and perimenopausal complexities, to improve diagnostic accuracy.
• Support the application of current evidence on novel therapeutics (e.g. NK3 blockers, testosterone) in menopausal symptom management.

After active participation in this program, learners will be able to:

• Integrate menopause screening and management into routine primary and specialty care encounters.
•  Distinguish between evidence-based and non-evidence-based information about menopause and hormone therapy.
•  Evaluate the safety, efficacy, and clinical indications for hormone therapy, including troubleshooting strategies for complex cases.
• Interpret the role of NK3 blockers and testosterone in managing menopausal symptoms based on current clinical evidence.
• Recognize overlapping symptoms such as ADHD and brain fog in midlife women, and apply appropriate diagnostic strategies.
• Assess the significance of breast density in menopausal patients and its implications for screening and care.
• Develop patient-centred communication strategies to address concerns, dispel myths, and support informed decision-making during the menopause transition.
• Collaborate with interdisciplinary colleagues to reflect on case complexities and shared strategies for managing perimenopausal and menopausal care.